AEROSOL IMMUNIZATION WITH DRY POWDER VACCINES AND TOXOIDS. COMMUNICATION, 9. FURTHER STUDY OF REACTIVENESS AND IMMUNOLOGICAL EFFECTIVENESS OF THE METHOD OF AEROSOL IMMUNIZATION WITH THE BRUCELLOSIS DUST VACCINE (AEROZOLNAYA IMMUNIZATSIYA SUKHIMI PYLEVYMI VAKTSINAMI I ANATOKSINAMI. SOOBSHCHENIE 9. DALNEISHEE IZUCHENIE REAKTOGENNOSTI I IMMUNOLOGICHESKOI EFFEKTIVNOSTI METODA AEROZOLNOI IMMUNIZATSII PYLEVOI BRUTSELLEZNOI VAKTSINOI)
Abstract
All virtually healthy people of both sexes, between the ages of 18 and 60, who have no medical contraindications to inoculations and are not sensitized to the brucellosis infection, can be admitted to aerosol immunization with the brucellosis dust vaccine. The optimal dose of the brucellosis dust vaccine, inhaled by the vaccinated person, is a dose equaling 250-820 (1000) million live Brucella of the vaccinal strain 19BA. In mass aerosol immunization of people with the brucellosis dust vaccine, the reactiveness of vaccinations is determined by the number of persons among them who are sensitized to brucellosis. In the absence of positive sero-allergic reactions in persons, who previously underwent subcutaneous (cutaneous) inoculations with the live brucellosis vaccine, their aerosol revaccination with the brucellosis dust vaccine did not produce any increased reaction. Aerosol immunization produced a rapid and long lasting immunologic reorganization of the organism of the vaccinated, which was registered, during the course of a year.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 1968
- Accession Number
- AD0672727
Entities
People
- K. G. Gapachko
- N. E. Gefen
- N. I. Aleksandrov
- N. S. Garin
- N. S. Maslov
Organizations
- United States Army Biological Warfare Laboratories